| Literature DB >> 27723844 |
Carlos Fernando Odir Rodrigues Melo1, Diogo Noin de Oliveira1, Estela de Oliveira Lima1, Tatiane Melina Guerreiro1, Cibele Zanardi Esteves1, Raissa Marques Beck2, Marina Aiello Padilla2, Guilherme Paier Milanez3, Clarice Weis Arns2, José Luiz Proença-Modena3, Jayme Augusto Souza-Neto4,5, Rodrigo Ramos Catharino1.
Abstract
Recent outbreaks of Zika virus in Oceania and Latin America, accompanied by unexpected clinical complications, made this infection a global public health concern. This virus has tropism to neural tissue, leading to microcephaly in newborns in a significant proportion of infected mothers. The clinical relevance of this infection, the difficulty to perform accurate diagnosis and the small amount of data in literature indicate the necessity of studies on Zika infection in order to characterize new biomarkers of this infection and to establish new targets for viral control in vertebrates and invertebrate vectors. Thus, this study aims at establishing a lipidomics profile of infected mosquito cells compared to a control group to define potential targets for viral control in mosquitoes. Thirteen lipids were elected as specific markers for Zika virus infection (Brazilian strain), which were identified as putatively linked to the intracellular mechanism of viral replication and/or cell recognition. Our findings bring biochemical information that may translate into useful targets for breaking the transmission cycle.Entities:
Mesh:
Year: 2016 PMID: 27723844 PMCID: PMC5056752 DOI: 10.1371/journal.pone.0164377
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Scores plot between the first two principal components (PCs) selected.
The explained variances are 33.5% for component 1 and 52.5% for component two.
Fig 2Clustering result for the 65 top features in the PLS-DA VIP scores, shown as a heat map (distance measured by Euclidean and clustering algorithm using ward.D), with a color-coded thermometer (bottom) indicating the relative concentrations of metabolites on each respective group.
Lipid markers elected by PLS-DA VIP scores ≥ 1.5 and elucidated by MS/MS for Aedes albopictus C6/36 infected cells (ZIKV group).
| Class | Ion ( | Molecule | MS/MS |
|---|---|---|---|
| Sphingolipid | 400 | Sphingofungin F | 311, 336, 356 |
| Phosphatidylserine | 516 | PS(18:4(6Z,9Z,12Z,15Z)/0:0) | 272, 289, 326, 345 |
| 518 | PS(18:3(9Z,12Z,15Z)/0:0) | 373, 387, 429, 474 | |
| 520 | PS(18:2(9Z,12Z)/0:0) | 375, 429, 431, 476 | |
| 540 | PS(20:6(2Z,5Z,8Z,11Z,14Z,17Z)/0:0) | 373, 395, 400, 491, 496, 522 | |
| 542 | PS(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) | 375, 402, 493, 498 | |
| 544 | PS(20:4(5Z,8Z,11Z,14Z)/0:0) | 355, 399, 456, 500 | |
| Phosphatidylcholine | 530 | PC(19:3(10Z,13Z,16Z)/0:0) | 472, 512 |
| 536 | PC(19:0/0:0) | 311, 404, 445, 447 | |
| 556 | PC(6:2(3E,5E)/14:2(11E,13E)) | 373, 389, 400, 416, 512 | |
| 558 | PC(6:2(3E,5E)/14:1(13E)) | 375, 402, 412, 418, 514 | |
| Dyacylglicerole | 563 | DG(16:1(9Z)/16:1(9Z)/0:0) | 519, 537, 545 |
| Phosphatidylethanolamine | 632 | PE(12:0/16:1(9Z)) | 544, 562, 588 |
Lipid markers elect by PLD-DA VIP score ≥ 1.5 and elucidated by MS/MS for Aedes albopictus C6/36 uninfected cells (Control group).
| Class | Ion (m/z) | Molecule | MS/MS |
|---|---|---|---|
| Phosphatidic Acid | 409 | PA(16:0/0:0) | 263, 365, 391 |
| Phosphoethanolamine | 757 | PE(18:2(9Z,12Z)/19:0) | 713, 730, 739 |
| 773 | PE(20:0/18:1(9Z)) | 627, 645, 728, 755 | |
| 779 | PE(16:0/22:6(54Z,7Z,10Z,12E,16Z,19Z)(14OH)) | 502, 546, 589, 735 | |
| Phosphatidylserine | 881 | PS(22:4(7Z,10Z,13Z,16Z)/21:0) | 736, 836, 863, |
| 903 | PS(22:0/22:0) | 714, 758, 858, 884 | |
| Triacylglycerol | 925 | TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) | 881, 899, 907 |
Fig 3Semi-quantitative analysis of characteristic lipids showed that ZIKV-infected cells.
The bars representing confidence interval of 95% (**** p<0.0001)
Fig 4Chemical images from MALDI-MSI showing the comparison between infected and uninfected cells.
It is visually possible to assess the difference in lipid composition of ZIKV-specific characterized biomarkers.